medroxyprogesterone has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, LV; Hayward, CS; Kelly, RP; Samaras, K; Sullivan, D | 1 |
| Bruni, B; Bruni-Bocher, K; Della Valle, A; Gamba, S | 1 |
1 trial(s) available for medroxyprogesterone and Diabetic Angiopathies
| Article | Year |
|---|---|
Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Composition; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipid Metabolism; Medroxyprogesterone; Middle Aged; Postmenopause; Risk Factors; Sexual Behavior | 1999 |
1 other study(ies) available for medroxyprogesterone and Diabetic Angiopathies
| Article | Year |
|---|---|
[Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
Topics: Adult; Aged; Aneurysm; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fluorescein Angiography; Growth Hormone; Humans; Insulin; Male; Medroxyprogesterone; Middle Aged; Pituitary Gland; Retinal Hemorrhage; Retinal Vessels | 1975 |